Polaris Pharmaceuticals is Biotechnology in United States that focus on ADI PEG business. Founded in 2006. They cover business area such as Polaris Group, novel anti-cancer therapy, (ADI PEG, a biologic, late-stage clinical development, hepatocellular carcinoma, mesothelioma, pancreatic cancer, non-small cell lung cancer, melanoma, acute myeloid leukemia, every stage.
2006
( 18 years old in 2024 )
ADI PEG
-
9373 Towne Centre Drive
Suite 150
San Diego, CA 92121
United States
Private
Polaris Groupnovel anti-cancer therapy(ADI PEGa biologiclate-stage clinical developmenthepatocellular carcinomamesotheliomapancreatic cancernon-small cell lung cancermelanomaacute myeloid leukemiaevery stage
* We use standard office opening hours in near Polaris Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Polaris Pharmaceuticals is Biotechnology business from United States that founded in 2006 (18 years old in 2024), Polaris Pharmaceuticals business is focusing on ADI PEG.
Polaris Pharmaceuticals headquarter office and corporate office address is located in 9373 Towne Centre Drive Suite 150 San Diego, CA 92121 United States.
Polaris Pharmaceuticals was founded in United States.
In 2024, Polaris Pharmaceuticals is currently focus on ADI PEG sector.
Above is snippet of Google Trends for "ADI PEG" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Polaris Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
